Pfizer, Inc. (PFE) Stock

About Pfizer, Inc.

Pfizer, Inc. is led by CEO Albert Bourla, employs 81,000 people, headquartered in New York City, US, publicly traded since 1972.

Pfizer, Inc. (PFE) stock trades at $27.82 with a market capitalization of $158.56B. The stock is valued at a price-to-earnings (P/E) ratio of 37.88, price-to-book of 1.92, price-to-sales of 2.57. Over the past 52 weeks the stock has ranged between $23.61 and $29.21, and currently trades 4.8% below its 52-week high. It pays a dividend yielding 6.00%.

On profitability, Pfizer, Inc. generates a return on equity (ROE) of 4.89%, return on capital employed of 9.48%, an operating margin of 24.67%, a net profit margin of 6.81%.

In its most recent fiscal year, Pfizer, Inc. reported annual revenue of $62.6B, net profit of $7.8B, revenue has compounded at 8.5% a year over the last five years, profit at -3.2% a year.

The balance sheet shows a debt-to-equity ratio of 0.74, a current ratio of 1.16, total assets of $208.2B, $1.1B in cash and equivalents.

PFE has a beta of 0.30 (less volatile than the overall market).